Reperfusion therapy in the acute management of ischemic stroke

Michelle P. Lin; Nerses Sanossian

doi:10.1016/j.ccl.2014.09.009

Reperfusion therapy in the acute management of ischemic stroke

Michelle P. Lin, Nerses Sanossian

Neurology

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Reperfusion, or restoration of blood flow, is an effective means of reducing disability in the setting of acute stroke. Reperfusion therapies, such as intravenous thrombolysis or endovascular and interventional procedures, fit within the existing stroke system of care. There are currently 4 devices cleared by the Food and Drug Administration for recanalization of arterial occlusion in patients with ischemic stroke. Endovascular device technology and advanced imaging technology continue to evolve with newer devices suggesting greater recanalization success. A new paradigm using advanced imaging to select patients in combination with newer devices is being tested and may lead to great improvements in care.

Original language	English (US)
Pages (from-to)	99-109
Number of pages	11
Journal	Cardiology clinics
Volume	33
Issue number	1
DOIs	https://doi.org/10.1016/j.ccl.2014.09.009
State	Published - 2015

Keywords

Acute ischemic stroke
American heart association
American stroke association
Intravenous recombinant tissue plasminogen activator (IV-tPA)
Mechanical thrombectomy
Stroke system of care
Thrombolysis in cerebral infarction (TICI score)

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ccl.2014.09.009

Cite this

@article{05bbd422aa5d432f9a65e0a6c771b087,

title = "Reperfusion therapy in the acute management of ischemic stroke",

abstract = "Reperfusion, or restoration of blood flow, is an effective means of reducing disability in the setting of acute stroke. Reperfusion therapies, such as intravenous thrombolysis or endovascular and interventional procedures, fit within the existing stroke system of care. There are currently 4 devices cleared by the Food and Drug Administration for recanalization of arterial occlusion in patients with ischemic stroke. Endovascular device technology and advanced imaging technology continue to evolve with newer devices suggesting greater recanalization success. A new paradigm using advanced imaging to select patients in combination with newer devices is being tested and may lead to great improvements in care.",

keywords = "Acute ischemic stroke, American heart association, American stroke association, Intravenous recombinant tissue plasminogen activator (IV-tPA), Mechanical thrombectomy, Stroke system of care, Thrombolysis in cerebral infarction (TICI score)",

author = "Lin, {Michelle P.} and Nerses Sanossian",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

doi = "10.1016/j.ccl.2014.09.009",

language = "English (US)",

volume = "33",

pages = "99--109",

journal = "Cardiology clinics",

issn = "0733-8651",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Reperfusion therapy in the acute management of ischemic stroke

AU - Lin, Michelle P.

AU - Sanossian, Nerses

PY - 2015

Y1 - 2015

N2 - Reperfusion, or restoration of blood flow, is an effective means of reducing disability in the setting of acute stroke. Reperfusion therapies, such as intravenous thrombolysis or endovascular and interventional procedures, fit within the existing stroke system of care. There are currently 4 devices cleared by the Food and Drug Administration for recanalization of arterial occlusion in patients with ischemic stroke. Endovascular device technology and advanced imaging technology continue to evolve with newer devices suggesting greater recanalization success. A new paradigm using advanced imaging to select patients in combination with newer devices is being tested and may lead to great improvements in care.

AB - Reperfusion, or restoration of blood flow, is an effective means of reducing disability in the setting of acute stroke. Reperfusion therapies, such as intravenous thrombolysis or endovascular and interventional procedures, fit within the existing stroke system of care. There are currently 4 devices cleared by the Food and Drug Administration for recanalization of arterial occlusion in patients with ischemic stroke. Endovascular device technology and advanced imaging technology continue to evolve with newer devices suggesting greater recanalization success. A new paradigm using advanced imaging to select patients in combination with newer devices is being tested and may lead to great improvements in care.

KW - Acute ischemic stroke

KW - American heart association

KW - American stroke association

KW - Intravenous recombinant tissue plasminogen activator (IV-tPA)

KW - Mechanical thrombectomy

KW - Stroke system of care

KW - Thrombolysis in cerebral infarction (TICI score)

UR - http://www.scopus.com/inward/record.url?scp=84923190893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923190893&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2014.09.009

DO - 10.1016/j.ccl.2014.09.009

M3 - Review article

C2 - 25439334

AN - SCOPUS:84923190893

SN - 0733-8651

VL - 33

SP - 99

EP - 109

JO - Cardiology clinics

JF - Cardiology clinics

IS - 1

ER -

Reperfusion therapy in the acute management of ischemic stroke

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this